NCT04387799View on ClinicalTrials.gov

Determinants of COVID-19 Pneumonia (MC-19)

CompletedOBSERVATIONAL

Enrollment

520

Participants

Timeline

Start Date

May 13, 2020

Primary Completion Date

June 12, 2020

Study Completion Date

June 17, 2020

Conditions

Pneumonia, ViralPneumonia, BacterialCoronavirus InfectionObstructive Lung Disease

Interventions

DIAGNOSTIC_TEST

Serology for Covid-19

Antibody tests designed to provide results to individuals or healthcare providers can show whether someone was previously infected with SARS-CoV-2 being the RT-PCR negative for the population of patients

Trial Locations (1)

00168

Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma

All Listed Sponsors

lead

Catholic University of the Sacred Heart

OTHER

NCT04387799 - Determinants of COVID-19 Pneumonia (MC-19) | Biotech Hunter | Biotech Hunter